A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
基本信息
- 批准号:8617090
- 负责人:
- 金额:$ 72.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-07 至 2016-02-29
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdrenergic AgonistsAfferent NeuronsAftercareAnatomic SitesAutomobile DrivingBehavioralBrain StemCalcium ChannelCalcium SignalingCervical spinal cord structureChronicClinicalComplexConfocal MicroscopyCytophotometryDataDevelopmentElectron MicroscopyGangliaGoalsHypersensitivityInjuryKnockout MiceLigandsMeasurementMediatingMediator of activation proteinModelingMusNerveNeuronsNociceptionOrofacial PainPainPathway interactionsPatientsPeripheralPeripheral nerve injuryPharmaceutical PreparationsPhysiologicalPlayPosterior Horn CellsProcessProtein SubunitsRattusRegulationRoleSamplingSensorySerotonin Receptors 5-HT-3SiteSliceSpinalSpinal CordSpinal nerve structureStructure of trigeminal ganglionSynapsesSynaptic TransmissionSyndromeTactileTertiary Protein StructureTestingTherapeutic AgentsTimeTrigeminal SystemTrigeminal nerve structureViralViral Vectorallodyniabasechannel blockerschronic constriction injurychronic paincraniofacialdigitalgabapentininterdisciplinary approachnerve injuryneuronal excitabilitynovelorofacialoverexpressionpainful neuropathypreventprogramspublic health relevancereceptorresearch studysynaptogenesisthrombospondin 4voltage
项目摘要
DESCRIPTION (provided by applicant): Chronic orofacial pain is a common clinical syndrome lacking specific and effective therapeutic agents due to the fact that cellular mechanisms of chronic orofacial pain are poorly understood. Based on our preliminary data from a trigeminal nerve injury model and in non-orofacial pain models, we hypothesize that trigeminal nerve injury induced thrombospondin-4 (TSP4) expression in trigeminal ganglia (TG) and associated brainstem/upper cervical spinal cord (Vc/C2) that causes sensory neuron hyperexcitability, and abnormal synaptogenesis in the trigeminal complex in the spinal cord. These changes underlie the transition from trigeminal nerve injury to chronic pain development. In this proposal, we plan to identify the critical domain(s) of TSP4 in mediating behavioral hypersensitivity and spinal neuron hyperexcitability. Viral driven TSP4 expression in TG or Vc/C2, respectively, will be used to identify the site of the TSP4's action in chronic pain processing. We will perform confocal and electron microscopy to determine the extent of abnormal synaptogenesis in the nerve injury models. In addition, the influence of descending modulatory pathways and voltage-gated-calcium channels on TSP4-mediated behavioral hypersensitivity and dorsal horn neuron hyperexcitability will be studies using respective drugs. The influence of TSP4 on sensory neuron excitability, calcium channel activities, and intracellular calcium signaling will be studied in isolated neurons or intact TG from nerve injury models, or after TSP4 treatment. To determine if TSP4 induces behavioral hypersensitivity and dorsal horn neuron hyperexcitability through its interactions with its receptor, the calcium channel alpha-2-delta-1 subunit (Cava2d1), in a sensory neuron specific manner, Cava2d1 conditional knockout mice with selective deletion of Cava2d1 in subpopulation of sensory neurons will be used for these studies. The final goal of the proposed studies is to identify the peripheral and/or central mechanisms underlying TSP4-mediated transition to chronic pain states after trigeminal nerve injury.
描述(申请人提供):慢性口腔面部疼痛是一种常见的临床综合征,由于慢性口腔面部疼痛的细胞机制尚不清楚,因此缺乏特定和有效的治疗药物。根据我们在三叉神经损伤模型和非口面部疼痛模型上的初步数据,我们假设三叉神经损伤诱导了三叉神经节(TG)和相关的脑干/上颈脊髓(VC/C2)的血栓反应蛋白-4(TSP4)的表达,从而导致感觉神经元的过度兴奋性,以及脊髓中三叉神经复合体的异常突触发生。这些变化为三叉神经损伤向慢性疼痛发展的过渡奠定了基础。在这项研究中,我们计划确定TSP4在调节行为超敏反应和脊髓神经元超兴奋性方面的关键结构域(S)。病毒驱动的TSP4在TG或VC/C2中的表达将被用来确定TSP4在慢性疼痛处理中的S作用部位。我们将通过共聚焦显微镜和电子显微镜来确定神经损伤模型中异常突触发生的程度。此外,下行调节通路和电压门控钙通道对TSP4介导的行为超敏和背角神经元超兴奋性的影响将分别用药物进行研究。TSP4对感觉神经元兴奋性、钙通道活性和细胞内钙信号的影响将在神经损伤模型的分离神经元或完整TG中或在TSP4处理后进行研究。为了确定TSP4是否通过与其受体--钙通道α-2-增量-1亚单位(Cava2d1)的相互作用,以感觉神经元特异性的方式诱导行为超敏反应和背角神经元的超兴奋性,我们将使用Cava2d1条件基因敲除小鼠进行这些研究。本研究的最终目的是确定三叉神经损伤后TSP4介导的向慢性疼痛状态转变的外周和/或中枢机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZHIGANG David LUO其他文献
ZHIGANG David LUO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZHIGANG David LUO', 18)}}的其他基金
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
验证阻断 TSP4/Cava2d1 相互作用作为神经性疼痛的新靶点
- 批准号:
10552492 - 财政年份:2022
- 资助金额:
$ 72.28万 - 项目类别:
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
验证阻断 TSP4/Cava2d1 相互作用作为神经性疼痛的新靶点
- 批准号:
10452913 - 财政年份:2021
- 资助金额:
$ 72.28万 - 项目类别:
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
验证阻断 TSP4/Cava2d1 相互作用作为神经性疼痛的新靶点
- 批准号:
10670457 - 财政年份:2019
- 资助金额:
$ 72.28万 - 项目类别:
Nanoparticle mediated in vivo cell-type specific drug delivery for pain relief
纳米颗粒介导体内细胞类型特异性药物递送以缓解疼痛
- 批准号:
8364809 - 财政年份:2012
- 资助金额:
$ 72.28万 - 项目类别:
Nanoparticle mediated in vivo cell-type specific drug delivery for pain relief
纳米颗粒介导体内细胞类型特异性药物递送以缓解疼痛
- 批准号:
8501694 - 财政年份:2012
- 资助金额:
$ 72.28万 - 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
- 批准号:
8101208 - 财政年份:2011
- 资助金额:
$ 72.28万 - 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
- 批准号:
8254372 - 财政年份:2011
- 资助金额:
$ 72.28万 - 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
- 批准号:
8420544 - 财政年份:2011
- 资助金额:
$ 72.28万 - 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
- 批准号:
8705625 - 财政年份:2011
- 资助金额:
$ 72.28万 - 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面神经病理性疼痛发展的新途径
- 批准号:
8804851 - 财政年份:2011
- 资助金额:
$ 72.28万 - 项目类别:
相似海外基金
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
- 批准号:
RGPIN-2014-06641 - 财政年份:2018
- 资助金额:
$ 72.28万 - 项目类别:
Discovery Grants Program - Individual
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
- 批准号:
RGPIN-2014-06641 - 财政年份:2017
- 资助金额:
$ 72.28万 - 项目类别:
Discovery Grants Program - Individual
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
- 批准号:
RGPIN-2014-06641 - 财政年份:2016
- 资助金额:
$ 72.28万 - 项目类别:
Discovery Grants Program - Individual
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
- 批准号:
RGPIN-2014-06641 - 财政年份:2015
- 资助金额:
$ 72.28万 - 项目类别:
Discovery Grants Program - Individual
Development of a new pharmacotherapy for heart failure using alpha-2 adrenergic agonists
使用 α-2 肾上腺素能激动剂开发治疗心力衰竭的新药物疗法
- 批准号:
15K09110 - 财政年份:2015
- 资助金额:
$ 72.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
- 批准号:
RGPIN-2014-06641 - 财政年份:2014
- 资助金额:
$ 72.28万 - 项目类别:
Discovery Grants Program - Individual
Reversing oxidative inhibition of the Na-K pump by beta3 adrenergic agonists: implications for heart failure therapy
β3 肾上腺素能激动剂逆转 Na-K 泵的氧化抑制:对心力衰竭治疗的影响
- 批准号:
nhmrc : 633252 - 财政年份:2010
- 资助金额:
$ 72.28万 - 项目类别:
NHMRC Project Grants
Research of the molecular mechanism in effects of doping drugs(adrenergic agonists)
兴奋剂药物(肾上腺素激动剂)作用的分子机制研究
- 批准号:
21500628 - 财政年份:2009
- 资助金额:
$ 72.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
EFFECTS OF ALPHA2-ADRENERGIC AGONISTS AND NMDA-ANTAGONISTS ON CEREBRAL MICROCIRCULATION UNDER THE HYPOTHERMIC CONDITION -ASSESSED WITH CLOSED CRANIAL WINDOW TECHNIQUE-.
α2-肾上腺素能激动剂和 NMDA 拮抗剂对低温条件下脑微循环的影响 - 用闭颅窗技术评估 -。
- 批准号:
11671489 - 财政年份:1999
- 资助金额:
$ 72.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
EFFECTS OF NMDA-ATAGONISTS AND ALPHA2-ADRENERGIC AGONISTS ON SPINAL AND CEREBRAL MICROCIRCULATION -ASSESSED WITH CLOSED SPINAL AND CRANIAL WINDOW TECHNIQUE-.
NMDA 激动剂和 α2 肾上腺素能激动剂对脊髓和大脑微循环的影响 - 使用闭合脊柱和颅窗技术进行评估 -。
- 批准号:
09671555 - 财政年份:1997
- 资助金额:
$ 72.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




